Dr. Sambursky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
217 Manatee Ave E
Bradenton, FL 34208Phone+1 941-748-1818Fax+1 941-746-1055
Summary
- Robert Sambursky, MD is an ophthalmologist based in Bradenton, FL. He completed his medical education at Boston University School of Medicine in 2000, followed by an internship in Internal Medicine at Mount Auburn Hospital, and a residency in Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital. Dr. Sambursky has specific experience in treating cornea/external disease and offering general/comprehensive ophthalmology. He has a notable record of publications in Clinical Ophthalmology and JAMA Ophthalmology, focusing largely on ocular surface inflammation and dry eye, and their management.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 2001 - 2004
Mount Auburn HospitalInternship, Internal Medicine, 2000 - 2001
Boston University School of MedicineClass of 2000
Certifications & Licensure
FL State Medical License 2005 - 2025
NY State Medical License 2005 - 2007
PA State Medical License 2001 - 2006
NJ State Medical License 2003 - 2005- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 126 citationsSensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye.Robert Sambursky, William F. Davitt, Robert Latkany, Shachar Tauber, Christopher E. Starr
JAMA Ophthalmology. 2013-01-01 - 36 citationsThe RPS adeno detector for diagnosing adenoviral conjunctivitis.Robert Sambursky, Shachar Tauber, Frank Schirra, Kristian Kozich, Richard Davidson
Ophthalmology. 2006-10-01 - 62 citationsProspective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease.Robert Sambursky, William F. Davitt, Murray Friedberg, Shachar Tauber
Cornea. 2014-08-01
Press Mentions
Visus Therapeutics Launches and Announces Clinical Development Program for Novel Presbyopia Eye DropSeptember 28th, 2020- FebriDx® Test Featured in UK National Institute for Health and Care Excellence (NICE) Medtech Innovation Briefing (MIB)September 8th, 2020
Lumos Diagnostics Supports the Victorian Healthcare System by Providing FebriDx® for a Pilot Evaluation in the Triaging of Acute Respiratory Infection PatientsMarch 26th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
